⌘K

Login Start Free

Home/Filings/4/0001104659-22-007841

4//SEC Filing

deVries Tina Marie 4

Accession 0001104659-22-007841

CIK 0001739426other

View on SEC.gov Company Profile

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 4:31 PM ET

Size

4.8 KB

Accession

0001104659-22-007841

Insider Transaction Report

Form 4

Period: 2022-01-24

RVL Pharmaceuticals plcRVLP

deVries Tina Marie

EVP, Research & Development

Transactions

Tax Payment
Ordinary Shares
2022-01-24$1.13/sh−9,607$10,856→ 141,588 total

Documents

1 file

4
tm223506-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

RVL Pharmaceuticals plc

CIK 0001739426

Entity typeother

Related Parties

1

filerCIK 0001750589

Filing Metadata

Form type: 4
Filed: Jan 25, 7:00 PM ET
Accepted: Jan 26, 4:31 PM ET
Size: 4.8 KB

View on SEC.gov